|
LRRFIP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.586400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.434400E-02 |
| Normal-vs-Stage2 |
3.973700E-02 |
| Normal-vs-Stage3 |
1.899250E-01 |
| Normal-vs-Stage4 |
4.345600E-01 |
| Stage1-vs-Stage2 |
5.250000E-01 |
| Stage1-vs-Stage3 |
8.397400E-01 |
| Stage1-vs-Stage4 |
6.924200E-01 |
| Stage2-vs-Stage3 |
5.174400E-01 |
| Stage2-vs-Stage4 |
4.486800E-01 |
| Stage3-vs-Stage4 |
8.291800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.560200E-02 |
| Normal-vs-AfricanAmerican |
7.802100E-02 |
| Normal-vs-Asian |
6.941800E-02 |
| Caucasian-vs-AfricanAmerican |
6.535600E-01 |
| Caucasian-vs-Asian |
1.728560E-01 |
| AfricanAmerican-vs-Asian |
1.269620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.721100E-03 |
| Normal-vs-Female |
4.843200E-01 |
| Male-vs-Female |
4.576200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.492300E-02 |
| Normal-vs-Extreme_Weight |
7.257600E-03 |
| Normal-vs-Obese |
2.389800E-01 |
| Normal-vs-Extreme_Obese |
6.325900E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.754200E-01 |
| Normal_Weight-vs-Obese |
2.086800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.628200E-01 |
| Extreme_Weight-vs-Obese |
1.089440E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.573800E-01 |
| Obese-vs-Extreme_Obese |
3.542800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.442000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.140200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.976300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.741990E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.206000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.286100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.779800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.277530E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.704100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.707800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.341700E-02 |
| Normal-VS-Type2 PRCC |
2.422700E-04 |
| Normal-VS-KIRP CIMP |
2.800000E-02 |
| Normal-VS-Unclassified PRCC |
1.697430E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.420700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.412400E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.724400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.144600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.354000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.503000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.407500E-04 |
| Normal-vs-N1 |
5.963200E-01 |
| Normal-vs-N2 |
6.107400E-01 |
| N0-vs-N1 |
1.823970E-02 |
| N0-vs-N2 |
5.351600E-01 |
| N1-vs-N2 |
8.518600E-01 |
|
|
